For more information regarding Bristol-Myers Squibb Clinical Trial participation, please
visit www.BMSStudyConnect.com
Inclusion Criteria:
  -  Completion of SLE Study (NCT03252587) through the protocol-required treatment period, and currently receiving blinded study drug
  -  Women of childbearing potential (WOCBP) must have a negative urine pregnancy test and must agree to use correctly a highly effective method(s) of contraception for the duration of treatment with study drug
Exclusion Criteria:
  -  Any disease or medical condition that, in the opinion of the investigator, would make the subject unsuitable for this study, would interfere with the interpretation of subject safety or study results, or considered unsuitable by the investigator for any other reason
  -  Evidence of active tuberculosis (TB)
Other protocol defined inclusion/exclusion criteria could apply